HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the ...
MSCs improve therapeutic consistency and precision across cell therapies. The approach also supports scalable allogeneic ...
It has only recently become known that two parallel systems of blood formation exist in the body, originating from different precursor cells. Researchers at the German Cancer Research Center (DKFZ) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results